Antiviral, antibacterial, and antiparasitic drugs and vaccines are essential to maintaining the
health of humans and animals. Yet, their production can be slow and expensive, and …

Emergence of drug resistance among the causative organisms for respiratory tract infections
represents a critical challenge to the global health care community. Further, although …

Pseudomonas aeruginosa (PA) is a multidrug-resistant (MDR) opportunistic pathogen
causing severe hospital-, and community-acquired infections worldwide. Thus, the …

This commentary summarizes the laboratory investigations and clinical trials published
recently involving per-oral application of IgY supplemented food for specific …

IgY-technology (the production and extraction of specific IgY antibodies from egg yolk) is an
innovative method to produce antibodies for therapy and prophylaxis. Advantages of IgY …

COVID-19 emergency use authorizations and approvals for vaccines were achieved in
record time. However, there remains a need to develop additional safe, effective, easy-to …

The world is facing one of the major outbreaks of viral infection of the modern history,
however, as vaccine development workflow is still tedious and can not control the infection …

Group A Rotaviruses are the most common cause of severe, dehydrating diarrhea in
children worldwide. The aim of the present work was to evaluate protection against rotavirus …

The rotavirus-induced diarrhea of human and animal neonates is a major public health
concern worldwide. Until recently, no effective therapy is available to specifically inactivate …

Pseudomonas aeruginosa is a common nosocomial pathogen in burn patients, and rapidly
acquires antibiotic resistance; thus, developing an effective therapeutic approach is the most …